131 related articles for article (PubMed ID: 9765021)
1. Cathepsin D expression in skin metastasis of breast cancer.
Inoue H; Kawada A; Takasu H; Maruyama R; Hata Y; Hiruma M; Tajima S; Ishibashi A
J Cutan Pathol; 1998 Aug; 25(7):365-9. PubMed ID: 9765021
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
Wallace ML; Longacre TA; Smoller BR
Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of monoclonal antibody HIK1083 specific for gastric O-glycan in differentiating cutaneous metastasis of gastric cancer from primary sweat gland carcinoma.
Iijima M; Nakayama J; Nishizawa T; Ishida A; Ishii K; Ota H; Katsuyama T; Saida T
Am J Dermatopathol; 2007 Oct; 29(5):452-6. PubMed ID: 17890913
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
[TBL] [Abstract][Full Text] [Related]
5. Significance of estrogen receptors and cathepsin D tissue detection in gastric adenocarcinoma.
Theodoropoulos GE; Lazaris AC; Panoussopoulos D; Davaris P; Golematis BC
J Surg Oncol; 1995 Mar; 58(3):176-83. PubMed ID: 7898114
[TBL] [Abstract][Full Text] [Related]
6. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte nuclear factor 4A expression discriminates gastric involvement by metastatic breast carcinomas from primary gastric adenocarcinomas.
Koyama T; Sekine S; Taniguchi H; Tsuda H; Ikegami M; Hano H; Kushima R
Hum Pathol; 2011 Nov; 42(11):1777-84. PubMed ID: 21733563
[TBL] [Abstract][Full Text] [Related]
8. [Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].
Zhou S; Yu B; Cheng Y; Xu X; Shui R; Bi R; Lu H; Tu X; Yang W
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):231-5. PubMed ID: 24915812
[TBL] [Abstract][Full Text] [Related]
9. Expression of bcl-2 by breast cancer: a possible diagnostic application.
Alsabeh R; Wilson CS; Ahn CW; Vasef MA; Battifora H
Mod Pathol; 1996 Apr; 9(4):439-44. PubMed ID: 8729986
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S
Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202
[TBL] [Abstract][Full Text] [Related]
11. Expression of pS2, c-erbB-2, and cathepsin D during the menstrual cycle in human breast cancers.
Khan SA; Gonchoroff NJ; Miller LE
Ann Surg Oncol; 1997 Sep; 4(6):462-9. PubMed ID: 9309334
[TBL] [Abstract][Full Text] [Related]
12. Biological and clinical significance of cathepsin D in breast cancer.
Rochefort H
Acta Oncol; 1992; 31(2):125-30. PubMed ID: 1622626
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical panel to differentiate metastatic breast carcinoma to skin from primary sweat gland carcinomas with a review of the literature.
Rollins-Raval M; Chivukula M; Tseng GC; Jukic D; Dabbs DJ
Arch Pathol Lab Med; 2011 Aug; 135(8):975-83. PubMed ID: 21809988
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cathepsin D as prognostic predictor in breast cancer.
Barbi GP; Margallo E; Margiocco M; Paganuzzi M; Marroni P; Costanzi B; Gatteschi B; Tanara G; Spina B; Nicolò G
Oncology; 1994; 51(4):329-33. PubMed ID: 8208515
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin D in breast cancer tissue.
Gonzalez Gancedo P; G-Casaus ML; Ruiz Cacho J; Calero F; Inocente JM; Gomez-Pastrana F; Ramon N
Int J Biol Markers; 1990; 5(4):203-6. PubMed ID: 1965545
[TBL] [Abstract][Full Text] [Related]
16. Expression of cathepsins B and D by cancer stem cells in head and neck metastatic malignant melanoma.
Sangster AB; Chang-McDonald B; Patel J; Bockett N; Paterson E; Davis PF; Tan ST
Melanoma Res; 2021 Oct; 31(5):426-438. PubMed ID: 34116545
[TBL] [Abstract][Full Text] [Related]
17. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma.
Wick MR; Ockner DM; Mills SE; Ritter JH; Swanson PE
Am J Clin Pathol; 1998 Jan; 109(1):75-84. PubMed ID: 9426521
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells.
Glondu M; Liaudet-Coopman E; Derocq D; Platet N; Rochefort H; Garcia M
Oncogene; 2002 Aug; 21(33):5127-34. PubMed ID: 12140763
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of immunohistochemical markers in primary lung and breast cancers enriched for triple-negative tumours.
Provenzano E; Byrne DJ; Russell PA; Wright GM; Generali D; Fox SB
Histopathology; 2016 Feb; 68(3):367-77. PubMed ID: 26118394
[TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical assessment of cathepsin D in gastric carcinoma: its impact on clinical prognosis.
Allgayer H; Babic R; Grützner KU; Beyer BC; Tarabichi A; Wilhelm Schildberg F; Heiss MM
Cancer; 1997 Jul; 80(2):179-87. PubMed ID: 9217027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
